Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug. The two patients, given ...

Regulators need to learn more about the excessive sedation triggered in some patients by a longer-lasting version of Eli Lilly and Co.'s top-selling drug Zyprexa before they can approve the treatment.

The Food and Drug Administration (FDA) stated that study results were inconclusive regarding the investigation of two deaths following the injection of Zyprexa Relprevv (olanzapine pamoate ...

INDIANAPOLIS Eli Lilly reported the receipt of a not-approvable letter on Thursday from the Food and Drug Administration for Zyprexa long-acting injection for the treatment and maintenance treatment ...

Two patients have died unexpectedly after their Zyprexa Relprevv injections, and the FDA is now investigating. The agency says the patients died three to four days after receiving "an appropriate dose ...

U.S. safety regulators are investigating two “unexplained” deaths possibly related to Eli Lilly’s (NYSE:LLY) Zyprexa injections, an antipsychotic drug used to treat mental disorders like schizophrenia ...

PISCATAWAY, N.J., July 30, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in ...

December 15, 2009 — The US Food and Drug Administration (FDA) has approved olanzapine extended-release intramuscular injection (Zyprexa Relprevv, Eli Lilly & Company) for the treatment of ...

Eli Lilly & Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug. The two patients, given ...

PISCATAWAY, N.J., July 30, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in ...